Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07679074 · ClinicalTrials.gov registry record
CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life
A clinical trial, sponsored by Samphire Group.
- Recruiting
- Registry status
- 50
- Enrollment target
NCT07679074: Recruiting study, sponsored by Samphire Group.
NCT07679074 is a clinical trial that is actively recruiting participants, run by Samphire Group. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07679074 is actively recruiting participants, sponsored by Samphire Group.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
This study evaluates the feasibility and efficacy of the Samphire Guided Care (SGC) program * a 12-week structured digital health program combining clinician-led onboarding, at-home neuromodulation using the Lutea tDCS device, neuromodulation coach support, and app-based symptom tracking - on work productivity, employee wellbeing, and quality of life in individuals experiencing mood and cognitive symptoms associated with menstruation, perimenopause, or menopause.
Primary Outcome
Within-participant change in WPAI Overall Work Impairment subscale score from baseline to end of program. Scores range from 0 to 100%, with higher scores indicating greater impairment. A reduction of 7 percentage points or more is considered clinically meaningful.
Interventions
- DEVICE Lutea Transcranial Direct Current Stimulation (tDCS) Device
- BEHAVIORAL Samphire Guided Care Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2027-03-01 |
What NCT07679074 shows while recruiting
NCT07679074 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Lutea Transcranial Direct Current Stimulation (tDCS) Device is the first listed.
NCT07679074 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07679074 about?
NCT07679074 is a clinical study titled "CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life". This study evaluates the feasibility and efficacy of the Samphire Guided Care (SGC) program * a 12-week structured digital health program combining clinician-led onboarding, at-home neuromodulation using the Lutea tDCS device, neuromodulation coach support, and app-based symptom tracking - on work ...
What is the current status of trial NCT07679074?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2026-06-01. Estimated completion is 2027-03-01.
What interventions are being tested in trial NCT07679074?
The interventions under investigation include: Lutea Transcranial Direct Current Stimulation (tDCS) Device (DEVICE), Samphire Guided Care Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT07679074?
This trial is sponsored by Samphire Group, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI